Skip to main content

Editorial Board

Editor-in-Chief
Yuichi Muraki, PhD, Kyoto Pharmaceutical University, Japan
(Medical Pharmacy, Clinical Pharmacy, Infectious Disease and Therapeutics, Clinical Pharmacoepidemiology)

 

Associate Editors

Yumiko Akamine, PhD, Akita University Hospital, Japan
(Pharmaceutical Health Care and Sciences, Pharmacokinetics)

Hirofumi Hamano, PhD, Okayama University Hospital, Japan
(Clinical Pharmacology)

Naoki Hara, PhD, Tokyo University of Pharmacy and Life Sciences, Japan
(Emergency and Critical Care, Clinical Infectious Diseases, Disaster Medicine, Cardiology, Simulation-Based Education)

Kenji Ikemura, PhD, Osaka University Hospital, Japan
(Clinical pharmacy, Pharmacokinetics, Clinical Pharmacology)

Hiroaki Ikesue, PhD, Kobe City Medical Center General Hospital, Japan
(Cancer Chemotherapy, Adverse Reaction)

Yoichi Ishitsuka, PhD, Kumamoto University, Japan
(Applied Pharmacology and Toxicology)

Shunji Ishiwata, PhD, Kindai University, Japan
(Hazardous Drug Exposure)

Keiji Izushi, PhD, Izushi Pharmacy Co., Ltd., Japan
(Pharmacy Services, Community Pharmacy, Clinical Pharmacy, Pharmacology)

Hirofumi Jono, PhD, Kumamoto University Hospital, Japan
(Clinical pharmacology, Molecular Medicine)

Kazuyoshi Kawakami, PhD, Cancer Institute Hospital of JFCR, Japan
(Oncology, Medication Adherece)

Hitoshi Kawazoe, PhD, Keio University, Japan
(Clinical Pharmacy, Clinical Oncology)

Kiyoyuki Kitaichi, PhD, Gifu Pharmaceutical University, Japan
(Pharmacokinetics)

Masaki Kobayashi, PhD, Hokkaido University, Japan
(Drug-drug interaction, Adverse effect, Clinical pharmacology/Toxicology, Pharmacokinetics, Pharmacotherapy, Transporter)

Yukinobu Kodama, PhD, Nagasaki University Hospital, Japan
(Clinical Pharmacy, Clinical Pharmaceutics, Cancer Chemotherapy, Pharmaceutical Science)

Masayoshi Koinuma, PhD, Teikyo Heisei University, Japan
(Biostatistics, Oriental Medicine, Clinical Pharmacology)

Tatsuya Kurihara, PhD, SHOWA University, Japan
(Pharmacoepidemiology, Pharmaceutical Education, Pharmacotherapeutics)

Kazuaki Matsumoto, PhD, Keio University, Japan
(Infectious disease, Infection control, Pharmacokinetics, Therapeutic Drug Monitoring)

Kenji Momo, PhD, Showa University, Japan
(Pharmacoepidemiology, Drug development,, Data Science, Hospital formulation, Applopriate Medication Use)

Shin-ya Morita, PhD, Shiga University of Medical Science Hospital, Japan
(Pharmacotherapeutics, Biochemistry and Biophysics of Lipids)

Shunsaku Nakagawa, PhD, Kyoto University Hospital, Japan
(Clinical Pharmacology, Pharmacoepidemiology, Drug-induced Nephropathy)

Tsutomu Nakamura, PhD, Osaka Medical and Pharmaceutical University, Japan
(Clinical Pharmacy)

Kazutaka Oda, PhD, Kumamoto University Hospital, Japan
(Therapeutic drug monitoring, Antimicrobial Chemotherapy, Pharmacometrics)

Tomohiro Omura, PhD, Kobe University Hospital, Japan
(Neuroscience (Neurodegenerative Disorders), Neuropharmacology, Clinical Pharmacology, Pharmaceutics and Hospital Preparation)

Kaname Ohyama, PhD, Nagasaki University Hospital, Japan
(Clinical Chemistry, Analytical Chemistry)

Mitsuo Saito, PhD,  Japan Pharmaceutical Information Center, Japan
(Drug information, Pharmacovigilance)

Junji Saruwatari, PhD, Kumamoto University, Japan
(Clinical Pharmacology)

Akitomo Shibata, PhD, Saiseikai Kumamoto Hospital, Japan
(Clinical Pharmacology, Clinical Pharmacokinetics, Emergency Medicine, Intensive Care Medicine)

Tomoya Tachi, PhD, Nagoya City University, Japan
(Clinical Pharmacy, Social Pharmacy, Pharmaceutical Education)

Yoshiko Tominaga, MBA, PhD, Niigata University of Pharmacy and Medical and Life Sciences, Japan
(Social Pharmacy, Healthcare Communication, Behavior Change, Pharmacist Professional Performance)

Masami Tsuchiya, PhD, Keio University, Japan
(Pharmacoepidemiology, Oncology (Cancer Chemotherapy and Supportive Care))

Masayuki Tsujimoto, PhD, Kyoto Pharmaceutical University, Japan
(Clinical Pharmacy, Biopharmaceutics)

Takehito Yamamoto, PhD, The University of Tokyo, Japan
(Clinical Pharmacokinetics, Therapeutic Drug Monitoring, Appropriate Use of Antibiotics, Blood Purification Therapy, Pharmacotherapy in Nephrology, Case Reports, Clinical Pharmacy, Pharmaceutical Education)

Shingo Yamazaki, PhD, Chiba University Hospital, Japan
(Therapeutic Drug Monitoring, Clinical Pharmacokinetics, Antimicrobial Stewardship)

Ryoichi Yano, PhD, Osaka Medical and Pharmaceutical University, Japan
(Clinical Pharmacy, Clinical Pharmacology, Pharmaceutical Education, Clinical Oncology, Women's Health)

Shodai Yoshihro, M Pharm, Hiroshima University Hospital, Japan
(Intensive Care Medicine, Perioperative Care, Cardiology,Infectious Diseases, Emergency Medicine, Pharmaceutical Education)

Editorial Advisory Board 
Masato Homma, PhD, University of Tsukuba Hospital, Japan
Ken-ichi Inui, PhD, Professor Emeritus of Kyoto University, Japan
Itsuko Ishii, PhD, Chiba University Hospital, Japan
Hiroki Ito, MD, PhD, Oita University Hospital, Japan
Kiyomi Ito, PhD, Musashino University, Japan
Takuya Iwamoto, PhD, Mie University Hospital, Japan
Junichi Kawakami, PhD, Hamamatsu University School of Medicine, Japan
Negishi Kenichi, PhD, Kitasato University, Japan
Yoshihisa Kitamura, PhD, Shujitsu University, Japan
Nariyasu Mano, PhD, Tohoku University Hospital, Japan
Masatomo Miura, PhD, Akita University Hospital, Japan
Tomoyuki Mizuno, PhD, Cincinnati Children's Hospital Medical Center and University of Cincinnati, USA
Kohji Naora, PhD, Shimane University Hospital, Japan
Atsumi Nitta, PhD, University of Toyama, Japan
Yoshihiro Noguchi, PhD, Gifu Pharmaceutical University, Japan
Hisakazu Ohtani, PhD, University of Tokyo, Japan
Yoshimichi Sai, PhD, Kanazawa University Hospital, Japan
Hideyuki Saito, PhD, Kumamoto University Hospital, Japan
Chisato Shimanoe, PhD, Saga University Hospital, Japan
James G Stevenson, PhD, University of Michigan, USA
Mitsuru Sugawara, PhD, Hokkaido University, Japan
Yoshikazu Tasaki, PhD, Asahikawa Medical University, Japan
Fe-Lin Lin Wu, PhD, National Taiwan University, Taiwan
Ikuko Yano, PhD, Kobe University Hospital, Japan

Official journal of JSPHCS

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.2
    5-year Journal Impact Factor: 1.4
    Source Normalized Impact per Paper (SNIP): 0.557
    SCImago Journal Rank (SJR): 0.312

    Speed 2024
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 79

    Usage 2024
    Downloads: 301,150
    Altmetric mentions: 116